United States & Frost & Sullivan

United States: The United States is noted as a major market where regulatory progress is supporting the development and expansion of the ergothioneine industry.

Frost & Sullivan: Frost & Sullivan published a white paper on the ergothioneine industry, positioning itself as a key source of market intelligence and strategic guidance for stakeholders in the health and wellness sector.

United States: The NYSE listing adds to the U.S. capital markets' diversity and signals openness to foreign issuers.

Frost & Sullivan: Provided market research data cited in the IPO, enhancing credibility.

Frost & Sullivan: Frost & Sullivan honored AT&T with the 2026 US Company of the Year Recognition, highlighting its role as an industry evaluator and recognizing excellence.

Frost & Sullivan: Frost & Sullivan published a market analysis report on the C5ISR industry in the United States, highlighting growth opportunities and increased funding, which positively impacts its reputation as a market intelligence provider.